{"schema_version":"1","generated_at":"2026-10-29T13:51:16.533Z","data_as_of":"2026-10-27","url":"https://www.findmykol.com/kol/ginette-okoye","json_url":"https://www.findmykol.com/kol/ginette-okoye/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"ginette-okoye","name":"Ginette Okoye","credential":"MD","title":"Associate Dean for Clinical Affairs; Professor and Chair of Dermatology, Howard University College of Medicine","specialty":"Dermatology","specialty_raw":"Dermatology","therapeutic_area":"Melanoma","therapeutic_areas":["Melanoma"],"institution":"Howard University Hospital","institution_url":"https://www.findmykol.com/institution/howard-university-hospital","city":"Washington","state":"DC","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1558547349","orcid":"0000-0003-1316-4023","openalex":"A5000011738"},"summary":"Ginette Okoye is Associate Dean for Clinical Affairs; Professor and Chair of Dermatology, Howard University College of Medicine at Howard University Hospital. OpenAlex indexes 124 publications with 2,077 citations (h-index 24); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.","overview":{"text":"Ginette A. Okoye, M.D., is Associate Dean for Clinical Affairs at Howard University Hospital (Professor and Department Chair). The public record shows 124 publications with 2,077 citations (h-index 24), centered on Hidradenitis Suppurativa and Treatments, Autoimmune and Inflammatory Disorders, Osteomyelitis and Bone Disorders Research. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 15 companies.","bullets":["Most recent indexed publication: 2022 · JMIR dermatology","Top research focus: Hidradenitis Suppurativa and Treatments","2 registered trials on ClinicalTrials.gov","Open Payments reporting from 15 companies"],"generated_at":"2026-10-28"},"focus":{"indications":[{"label":"Keloid","therapeutic_area":"Rheumatology/Immunology","trials":1,"topics":0,"strength":3},{"label":"Vitiligo","therapeutic_area":"Dermatology","trials":1,"topics":0,"strength":3},{"label":"Atopic Dermatitis / Eczema","therapeutic_area":"Dermatology","trials":0,"topics":1,"strength":1},{"label":"Acne / Hidradenitis","therapeutic_area":"Dermatology","trials":0,"topics":1,"strength":1}],"research_topics":["Hidradenitis Suppurativa and Treatments","Autoimmune and Inflammatory Disorders","Osteomyelitis and Bone Disorders Research","Dermatology and Skin Diseases","Cutaneous lymphoproliferative disorders research"],"drugs_studied":{"total":11,"shown":3,"withheld":8,"rows":[{"name":"Skyrizi","generic":"Risankizumab","trials":0,"payments":7,"publications":0,"mentions":7},{"name":"Bimzelx","generic":"Bimekizumab","trials":0,"payments":6,"publications":0,"mentions":6},{"name":"Cosentyx","generic":"Secukinumab","trials":0,"payments":3,"publications":0,"mentions":3}]},"works_with":{"total":16,"shown":3,"withheld":13,"rows":[{"name":"Abbvie Inc.","trials":0,"payments":21,"mentions":21},{"name":"UCB, Inc.","trials":0,"payments":7,"mentions":7},{"name":"Janssen Research & Development, LLC","trials":0,"payments":4,"mentions":4}]}},"scholarship":{"works_count":124,"cited_by_count":2077,"h_index":24,"i10_index":54,"pubmed_count":9,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT02996097","title":"Fractional Laser Assisted Steroid Therapy vs Intralesional Steroids in the Treatment of Keloids","phase":"NA","status":"COMPLETED","role":"Investigator","sponsor":"Johns Hopkins University","source_url":"https://clinicaltrials.gov/study/NCT02996097","trial_url":"https://www.findmykol.com/trial/NCT02996097"},{"nct":"NCT02506101","title":"Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo","phase":"NA","status":"TERMINATED","role":"Investigator","sponsor":"Johns Hopkins University","source_url":"https://clinicaltrials.gov/study/NCT02506101","trial_url":"https://www.findmykol.com/trial/NCT02506101"}],"source":"trials"},"payments":{"company_count":15,"program_years":{"first":2021,"last":2025},"rows_total":22,"shown":3,"withheld":19,"rows":[{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":6862.95,"payment_count":15,"source_url":"https://openpaymentsdata.cms.gov/search?query=1558547349"},{"payer":"UCB, Inc.","program_year":2025,"amount_usd":3547.25,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1558547349"},{"payer":"Regeneron Healthcare Solutions, Inc.","program_year":2025,"amount_usd":21.15,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1558547349"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1558547349","source":"payments"},"prescribing":{"data_year":2024,"areas_total":2,"areas_shown":2,"areas":[{"area":"Anti-infectives","share_pct":50,"classes_total":1,"classes":[{"class":"Lincosamide Antibacterial","setting":"prescribed","share_pct":50,"drugs":[{"name":"Clindamycin Hcl","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":50,"classes_total":1,"classes":[{"class":"Interleukin-17A Antagonist","setting":"prescribed","share_pct":50,"drugs":[{"name":"Cosentyx Sensoready (2 Pens)","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":1,"years":{"first":2025,"last":2025},"societies":["ENDO"],"shown":1,"withheld":0,"rows":[{"title":"MON-590 An Analysis of Inflammatory and Metabolic Markers in Hidradenitis Suppurativa: A Preliminary Assessment of TNF-α","society":"ENDO","meeting":"ENDO Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1210/jendso/bvaf149.953","source_url":"https://doi.org/10.1210/jendso/bvaf149.953","status":"verified"}],"source":"congress"},"publications":{"total":9,"shown":5,"withheld":4,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Geospatial Heterogeneity of Hidradenitis Suppurativa Searches in the United States: Infodemiology Study of Google Search Data.","year":2022,"journal":"JMIR dermatology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/37632873/","status":"verified"},{"title":"Treating hidradenitis suppurativa during the COVID-19 pandemic: teledermatology exams of sensitive body areas.","year":2022,"journal":"The Journal of dermatological treatment","types":["Letter"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/32643464/","status":"verified"},{"title":"Lessons learned from the development of a hidradenitis suppurativa xenograft mouse model.","year":2020,"journal":"Clinical and experimental dermatology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/31322280/","status":"verified"},{"title":"Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa.","year":2019,"journal":"Science translational medicine","types":["Journal Article","Research Support, N.I.H., Intramural","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/31484788/","status":"verified"},{"title":"Collagen deposition in chronic hidradenitis suppurativa: potential role for CD163(+) macrophages.","year":2018,"journal":"The British journal of dermatology","types":["Letter","Research Support, N.I.H., Extramural"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/29603182/","status":"verified"}],"most_cited":{"total":124,"shown":5,"withheld":119,"rows":[{"title":"Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa","year":2019,"cited_by_count":182,"type":"article","source_url":"https://doi.org/10.1126/scitranslmed.aav5908"},{"title":"Age, Race, Sex, Stage, and Incidence of Cutaneous Lymphoma","year":2012,"cited_by_count":149,"type":"article","source_url":"https://doi.org/10.1016/j.clml.2012.06.010"},{"title":"Absence of images of skin of colour in publications of COVID‐19 skin manifestations","year":2020,"cited_by_count":99,"type":"article","source_url":"https://doi.org/10.1111/bjd.19258"},{"title":"Noncoding dsRNA induces retinoic acid synthesis to stimulate hair follicle regeneration via TLR3","year":2019,"cited_by_count":91,"type":"article","source_url":"https://doi.org/10.1038/s41467-019-10811-y"},{"title":"Patterns of antimicrobial resistance in lesions of hidradenitis suppurativa","year":2016,"cited_by_count":87,"type":"article","source_url":"https://doi.org/10.1016/j.jaad.2016.08.001"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Angel S. Byrd","coauthored_works":39},{"name":"Sewon Kang","coauthored_works":14,"profile_url":"https://www.findmykol.com/kol/sewon-kang"},{"name":"Carmelo Carmona‐Rivera","coauthored_works":14}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/ginette-okoye-md","status":"provisional"}]},"mentions":{"total":1,"shown":1,"rows":[{"url":"https://profiles.howard.edu/ginette-okoye","platform":"other","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"M.D., Columbia University College of Physicians and Surgeons (2005)","source_url":"https://profiles.howard.edu/ginette-okoye","status":"verified","collected_at":"2026-10-28"},{"value":"B.S. in Biology, Barry University (2000)","source_url":"https://profiles.howard.edu/ginette-okoye","status":"verified","collected_at":"2026-10-28"}]},"roles":{"total":1,"shown":1,"rows":[{"value":"Editor, The Fundamentals of Ethnic Hair: The Dermatologist's Perspective","source_url":"https://profiles.howard.edu/ginette-okoye","status":"verified","collected_at":"2026-10-28"}]},"awards":{"total":9,"shown":3,"rows":[{"value":"American Academy of Dermatology Presidential Citation Award (2026)","source_url":"https://profiles.howard.edu/ginette-okoye","status":"verified","collected_at":"2026-10-28"},{"value":"A. Paul Kelly, MD Research Award and Lectureship (2023)","source_url":"https://profiles.howard.edu/ginette-okoye","status":"verified","collected_at":"2026-10-28"},{"value":"Howard University Medical Student Teaching Award (2023)","source_url":"https://profiles.howard.edu/ginette-okoye","status":"verified","collected_at":"2026-10-28"}]},"secondary_affiliations":{"total":3,"shown":3,"rows":[{"value":"Johns Hopkins School of Medicine (Associate Professor), past","source_url":"https://orcid.org/0000-0003-1316-4023","status":"verified","collected_at":"2026-10-28"},{"value":"Yale University, dermatology residency (completed)","source_url":"https://profiles.howard.edu/ginette-okoye","status":"verified","collected_at":"2026-10-28"},{"value":"Hidradenitis Suppurativa Foundation (joined to work on patient quality of life and access to care)","source_url":"https://www.hs-foundation.org/ginette-okoye-md","status":"verified","collected_at":"2026-10-28"}]},"media":{"total":1,"shown":1,"rows":[{"value":"Dermcast.tv interview on the psychosocial impact, diagnosis and treatment of alopecia (\"Dr. Ginette Okoye gives insight on alopecia and the alopecia patient\"), undated, about 7 years old at retrieval","source_url":"https://dermcast.live/dr-ginette-okoye/amp/","status":"verified","collected_at":"2026-10-28"}]}},"similar":[{"name":"Jedd Wolchok","slug":"jedd-wolchok","institution":"Weill Cornell Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jedd-wolchok","json_url":"https://www.findmykol.com/kol/jedd-wolchok/profile.json"},{"name":"Frank Hodi","slug":"frank-hodi","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/frank-hodi","json_url":"https://www.findmykol.com/kol/frank-hodi/profile.json"},{"name":"Keith Flaherty","slug":"keith-flaherty","institution":"Massachusetts General Hospital","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/keith-flaherty","json_url":"https://www.findmykol.com/kol/keith-flaherty/profile.json"},{"name":"Omid Hamid","slug":"omid-hamid","institution":"The Angeles Clinic and Research Institute","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/omid-hamid","json_url":"https://www.findmykol.com/kol/omid-hamid/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":19,"publications":4,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-28"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-28"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-10-28"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-28"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-28"}},"methodology_url":"https://www.findmykol.com/about#methodology"}